Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results
Date:11/5/2013

SAN DIEGO, Nov. 5, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the three and nine months ended September 30, 2013.

Highlights for the third quarter of 2013 included:

  • Net product revenue for the third quarter of 2013 was $29.0 million, representing increases of $15.1 million, or 109%, from the third quarter of 2012, and $4.3 million, or 17%, from the second quarter of 2013.
  • Gross margin on sales of OFIRMEV was 66% for the third quarter of 2013, compared to 56%, for the third quarter of 2012.
  • The number of unique end-user customer accounts that ordered OFIRMEV during the third quarter of 2013 increased 33% as compared to the same period in 2012.
  • The average order size per end-user customer increased 22% during the third quarter of 2013 as compared to the third quarter of 2012.
  • The average number of orders per end-user customer increased approximately 8% during the third quarter of 2013, as compared to the third quarter of 2012.
  • "We maintained our strong performance during the third quarter, with OFIRMEV continuing to gain market share and posting year-over-year sales growth of more than 100% in each quarter of 2013," said Ted Schroeder, President and CEO of Cadence. "In addition, our disciplined approach to controlling expenses has enabled us to reduce our cash burn despite the legal expenses we continue to incur to defend the intellectual property covering OFIRMEV."Financial Results
    Cadence's net product revenue for the three months ended September 30, 2013 was $29.0 million, an increase of 109%, from the $13.9 million in net product revenue recognized for the three months ended September 30, 2
    '/>"/>

    SOURCE Cadence Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013
    2. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013
    3. Cadence Pharmaceuticals Comments on USPTOs Non-Final, Initial Office Action on Reexamination of Patent
    4. Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
    5. Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
    6. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
    7. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
    8. Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
    9. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
    10. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
    11. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/30/2014)... -- , A series of Health ... change the way retail pharmaceutical companies are perceived   ... and view pharmacies, Health First Pharmacy is redefining the ... very trendy public demands of customisation and accessibility, the ... various activities for both children and adults starting from ...
    (Date:9/30/2014)... -- RFID Journal announced today that registration is now open for ... industry event focused on the use of radio frequency ... and exhibition will be held on Nov. 20, 2014, ... Chicago, Ill. RFID in Health ... use RFID to improve asset-utilization rates, reduce expenses and ...
    (Date:9/30/2014)... , Sept. 30, 2014 ... CHDX ) today announced the completion of its ... $24.00 per share in cash.  Healthy Harmony is an ... ("Fosun") and Ms. Roberta Lipson , the CEO ... agreement was adopted by Chindex,s stockholders at a special ...
    Breaking Medicine Technology:Health First Pharmacy Redefines 'Pharmacy Retail Experience' 2Health First Pharmacy Redefines 'Pharmacy Retail Experience' 3Hear New Case Studies from Industry Leaders at RFID in Health Care 2014 2Hear New Case Studies from Industry Leaders at RFID in Health Care 2014 3Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 2Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 3Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 4Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 5
    (Date:9/30/2014)... TUESDAY, Sept. 30, 2014 (HealthDay News) -- In books and ... abound. Now, new research suggests that the ... study, psychologists looked at data on more than 12,000 people ... Abo Akademi in Turku, Finland, found that women typically preferred ... this remained consistent throughout their lives. On the other ...
    (Date:9/30/2014)... Jersey (PRWEB) September 30, 2014 Visiting ... visiting nurse association—is pleased to announce that Steven Landers, ... with a NJBIZ “40 Under 40” award on ... Jersey’s most accomplished young businessmen and women who have ... a commitment to business growth, professional excellence and to ...
    (Date:9/30/2014)... 30, 2014 AxoGen, Inc. (NASDAQ: ... the peripheral nerve repair market, announced the presentation of ... American Society for Surgery of the Hand (ASSH) 2014 ... , The ASSH Best Paper Award ... Processed Nerve Allografts for Large Gap Nerve Discontinuities: Outcomes ...
    (Date:9/30/2014)... (PRWEB) September 30, 2014 AutoTex ... sporting the iconic pink ribbon in support of breast ... popular month for businesses and non-profits to “go pink” ... cause. , AutoTex PINK is a woman-owned company that ... They are committed to partnering with their customers ...
    (Date:9/30/2014)... (PRWEB) September 30, 2014 ... ADVISORY** , From:        Hope For ... 910.554.1505, abarnwell(at)hopeforthewarriors(dot)org , ... Celebration , Date:        Thursday, October ... Army and Navy Club, ...
    Breaking Medicine News(10 mins):Health News:When It Comes to Sex Partners, Men Prefer Younger Women: Study 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 2Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 4Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 5Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 2Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 3Health News:Hope For The Warriors' Got Heart, Give Hope Celebration Media Advisory 2
    ... May 18 (HealthDay News) -- Inflammation caused by chronic heartburn ... finds. The condition -- formally known as gastroesophageal reflux ... of the esophagus doesn,t close properly, allowing stomach contents to ... can lead to changes in the tissue lining the esophagus, ...
    ... Steven Reinberg HealthDay Reporter , THURSDAY, May ... Administration on Thursday approved generic versions of the blood ... affordable for those patients who need it. ... effective and affordable treatment options is important. The generic ...
    ... and precisely deflected, shaped and focused. If we pulse ... the laser tool works even more precisely. A benefit: ... High-power, ultra-short pulses, then, are the ideal solution for ... cerebral membrane is not damaged. Or for removing tumor ...
    ... Endocrine Society,s new scientific statement published online today ... basic and clinical evidence related to the non-skeletal ... research regarding the associations of vitamin D with ... health. Vitamin D is a steroid hormone ...
    ... be detected at birth, according to new research at ... babies with a better innate response to viruses have ... "Viral respiratory infections are common during childhood," says ... "Usually they are mild, but there,s a wide range ...
    ... Parents of young children with epilepsy often sleep in the ... monitor their condition, but the bed-sharing may be interfering with ... finds. In the study, published in the journal ... Boston examined the sleeping arrangements of 105 families who had ...
    Cached Medicine News:Health News:Chronic Heartburn May Boost Risk for Esophageal Cancer 2Health News:FDA Approves Generic Versions of Plavix 2Health News:FDA Approves Generic Versions of Plavix 3Health News:Ultra-short laser pulses for science and industry 2Health News:Experts call for clinical trials to test non-skeletal benefits of vitamin D 2Health News:Babies' susceptibility to colds linked to immune response at birth 2Health News:Babies' susceptibility to colds linked to immune response at birth 3Health News:Parents Often Lose Sleep Over Child's Epilepsy, Study Finds 2
    ... in the field of hammertoe implants with the ... grade silicone, these durable and lasting implants will ... flexibility while maintaining correct toe length and shape. ... Lengths are determined by the surgeon for each ...
    ... Implant (KGTI) system offers the latest technology ... MPJ. The implant system is anatomically designed ... ,The KGTI is the most advanced reconstructive ... on the market today. The system consists ...
    ... has been approved for use as an ... seizures in adults and adolescents over 12 ... that are refractory to antiepileptic medications. This ... controlled, clinical trials. Efficacy, measured as median ...
    Ad-Techs Spinal Electrodes are intended for intraoperative monitoring of Evoked Potentials (EPs) of the descending pathway during spinal surgery. They are offered with 2 or 3 platinum contacts....
    Medicine Products: